Evidence map›Paper›PMID 35930505›Full record

ReviewHuman vaccines & immunotherapeutics2022

Fielding vaccines-challenges and opportunities in outbreaks, complex emergencies, and mass gatherings.

Laura J Fischer, Robert C Rains, Sherry M Brett-Major, Mikiko Senga, Debra Holden, David M Brett-Major

Open access · goldAbstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Laura J FischerDepartment of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID 0000-0003-4348-4968
Robert C RainsARC Operational Development, Washington, District of Colombia, USA.
Sherry M Brett-MajorBrett-Major Law, Bethesda, Maryland, USA.
Mikiko SengaDepartment of Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Debra HoldenVeritas Management Group, Alpharetta, Georgia, USA.
David M Brett-MajorDepartment of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.
University of Nebraska Medical Center · USLondon School of Hygiene & Tropical Medicine · GBVeritas (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the recent COVID-19 pandemic, the importance of vaccine development, distribution, and uptake has come to the forefront of the public eye. Effectively fielding vaccines during an emergency-whether that emergency is a result of an infectious disease or not-requires an understanding of usual vaccine-related processes; the impact of outbreak, complex emergencies, mass gatherings, and other events on patients, communities, and health systems; and ways in which diverse resources can be applied to successfully achieve needed vaccine uptake. In this review, both the emergency setting and briefly vaccine product design are discussed in these contexts in order to provide a concise source of general knowledge from experts in fielding vaccines that can aid in future vaccine ventures and increase general awareness of the process and barriers in various settings.

Indexed as

COVID-19VaccinesDisease OutbreaksEmergenciesHumansMass GatheringsPandemicsVaccinesdisasteremergencyoutbreak responseVaccine logistics

Identifiers

PMID35930505
PMCPMC9746477
OpenAlexW4289946781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.